Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
| Year | 2022 |
| Author | 柯冠銘* |
| Author count | 1 |
| Created date | 2022-09-24 |
| Author order | 第一作者 |
| Corresponding author | 是 |
| Publication year | 2022 |
| Publication month | 5 |
| Journal name | Vaccines (Basel) |
| Publication area | 瑞士聯邦 |
| Volume | 10 |
| Issue | 5 |
| Publication type | |
| Review system | 是 |
| Language | Foreign Language |